Response to Mavacamten in Patients With High Baseline Left Ventricular Filling Pressures in the EXPLORER-HCM Trial

Affiliations

• ¹ Cardiovascular Division, Department of Medicine (S.C., R.G.B.), Washington University School of Medicine, St. Louis, MO.
• ² Department of Genetics (S.C.), Washington University School of Medicine, St. Louis, MO.
• ³ Perelman School of Medicine, University of Pennsylvania, Philadelphia (A.T.O.).
• ⁴ Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (N.K.L., S.M.H.).
• ⁵ University of Michigan, Ann Arbor (S.S.).
• ⁶ Duke Clinical Research Institute, Durham, NC (E.K.N., D.M.W.).
• ⁷ Bristol Myers Squibb, Princeton, NJ (A.J.S.*).
• ⁸ Duke University Medical Center, Durham, NC (A.W.). *At the time the analysis was conducted.